News Today AMLX Stock – Today on Tuesday 29 July 2025 Amylyx Pharmaceuticals Inc stock opened at $8.06, surges by 0.12 percent compared to the previous close of $7.99. While Amylyx Pharmaceuticals Inc stock touched an intraday high of $8.10, and intraday low of $7.84 at 10.43 AM. Right now, AMLX stock jumped around 0.12% and traded at $8.00.
As of Tuesday 29 July 2025, AMLX stock plummeted over -8.26 percent from its 52-week high and soared by 354.55 percent from its 52-week low till 10.43 AM.
Today on Tuesday 29 July 2025, AMLX stock 10 days average trading volume stood at 1.3703 million stocks, while the 3 months average volume stood at 1.26125 million stocks. However, the intraday trading range of AMLX stock is $7.84 – 8.095 till 10.43 AM.
According to the market exchange data available on Tuesday 29 July 2025, the Industry company’s market capitalization stands at $712.24 Million USD. The AMLX P/E ratio (TTM) is approximately N/A and BETA is around -0.44 till 10.43 AM.
Tuesday 29 July 2025 – Return delivered by Amylyx Pharmaceuticals Inc Stock
Since today, Tuesday 29 July 2025, over the last 3-month (13 Week Return) period AMLX Stock price has delivered a positive return of 52.4809% to investors. If investors had invested $1,000 in AMLX stock, you’d have $1524.8 till today on Tuesday 29 July 2025.
However, Amylyx Pharmaceuticals Inc Stock has delivered a positive return of 131.5942% to investors over the last 6-months (26 Week Return). Means if investors had invested $1,000 in AMLX stock, you’d have $2315.9 till today.
Over the last 1-year (52 Week Return) period from Tuesday 29 July 2025, Amylyx Pharmaceuticals Inc Stock has delivered positive returns of 316.1458% to investors. Means if investors had invested $1,000 in Amylyx Pharmaceuticals Inc stock, you’d have $4161.5 till today on Tuesday 29 July 2025.
Forecaster – US market experts rating on Amylyx Pharmaceuticals Inc stock
- Out of the 15 analysts tracking this stock, Hold call from 2 analysts.
- BUY call from 6 analysts.
- SELL call from 0 analysts.
Amylyx Pharmaceuticals Inc Prediction made by Goldman Sachs analysts
As per latest update received from Wall Street sources on Tuesday 29 July 2025, Goldman Sachs analysts set the Health Care company Amylyx Pharmaceuticals Inc stock price target to $10 with a BUY call. Goldman Sachs analysts have set the stock price forecast, which is indicating 25% upside from the current level of AMLX stock price of $8.
